|
CDKAL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.051800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.486230E-01 |
| Normal-vs-Stage2 |
5.866000E-01 |
| Normal-vs-Stage3 |
2.230800E-01 |
| Normal-vs-Stage4 |
3.468200E-01 |
| Stage1-vs-Stage2 |
1.440620E-01 |
| Stage1-vs-Stage3 |
9.815400E-01 |
| Stage1-vs-Stage4 |
7.764400E-01 |
| Stage2-vs-Stage3 |
1.374630E-01 |
| Stage2-vs-Stage4 |
2.369000E-01 |
| Stage3-vs-Stage4 |
7.982400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.798000E-02 |
| Normal-vs-AfricanAmerican |
7.599600E-01 |
| Normal-vs-Asian |
3.118600E-01 |
| Caucasian-vs-AfricanAmerican |
4.166200E-01 |
| Caucasian-vs-Asian |
6.915200E-01 |
| AfricanAmerican-vs-Asian |
6.138800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.117220E-01 |
| Normal-vs-Female |
3.238000E-01 |
| Male-vs-Female |
3.150800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.138950E-01 |
| Normal-vs-Age(41-60Yrs) |
2.290800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.099200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.232600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.110600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.887800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.760800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.413030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.990200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.987800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.708600E-01 |
| Classical-VS-Follicular |
8.93729534823251E-14 |
| Classical-VS-Other |
4.148000E-02 |
| Classical-VS-Normal |
6.619500E-03 |
| Tall-VS-Follicular |
1.443940E-04 |
| Tall-VS-Other |
8.486000E-02 |
| Tall-VS-Normal |
1.022600E-01 |
| Follicular-VS-Other |
6.362400E-01 |
| Follicular-VS-Normal |
1.464630E-03 |
| Other-VS-Normal |
3.051400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.031200E-01 |
| Normal-vs-N1 |
2.020600E-01 |
| N0-vs-N1 |
2.892200E-01 |
|
|
